Hyam Levitsky
CIK 1375792 · President of R&D · last filed 2024-04-03
Hyam Levitsky is a President of R&D who has filed 28 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing, for REPL, was dated Apr 3, 2024. Across all open-market trades the lifetime net is −$531.1K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.1M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.15M
4
28
-$531.1K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| REPL | Director | — | $5.35 | — | $0 | 7 | 2024-04-03 |
| IPSC | President of R&D | 560,544 | $2.05 | $1.15M | $0 | 3 | 2024-03-11 |
| Juno Therapeutics, Inc. (JUNO) Delisted | EVP, Research & CSO | 131,334 | — | — | -$531.1K | 5 | 2017-02-09 |
| AGEN | Director | 128 | $6.60 | $845 | $0 | 13 | 2011-07-06 |
Recent Filings
28 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-04-03 | REPL | Grant (A) | — | $0 | EDGAR |
| 2024-03-11 | IPSC | Grant (A) | +24,000 | $0 | EDGAR |
| 2023-04-14 | IPSC | Grant (A) | — | $0 | EDGAR |
| 2023-04-04 | REPL | Grant (A) | — | $0 | EDGAR |
| 2022-04-05 | REPL | Grant (A) | — | $0 | EDGAR |
| 2022-01-27 | IPSC | Grant (A) | — | $0 | EDGAR |
| 2021-04-05 | REPL | Grant (A) | — | $0 | EDGAR |
| 2020-04-02 | REPL | Grant (A) | — | $0 | EDGAR |
| 2019-04-03 | REPL | Grant (A) | — | $0 | EDGAR |
| 2018-07-26 | REPL | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.